Sirdás sisdollui
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Giella
Buot deaivamat
Bajilčálus
Dahkki
Fáddá
Hildobáiki
ISBN/ISSN
Fáddágilkor
Viečča
Aiddostahtton
No Impact of KIF6 Genotype on...
Čujuhandieđut
Deakstadieđáhus
Sádde šleađgaboasttain
Čálit
Doalvvo čujuhusa
Doalvun: RefWorks
Doalvun: EndNoteWeb
Doalvun: EndNote
Bissovaš liŋka
No Impact of KIF6 Genotype on Vascular Risk or Statin Benefit in the Heart Protection Study
Bibliográfalaš dieđut
Váldodahkkit:
Hopewell, J
,
Parish, S
,
Clarke, R
,
Armitage, J
,
Collins, R
,
Collaborati, H
Materiálatiipa:
Conference item
Almmustuhtton:
2009
Oažžasuvvandieđut
Govvádus
Geahča maid
Bargiidšearbma
Geahča maid
No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.
Dahkki: Hopewell, J, et al.
Almmustuhtton: (2011)
No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.
Dahkki: Hopewell, J, et al.
Almmustuhtton: (2011)
Genetic variation in lipid response to statin therapy in 18,705 participants in the heart protection study
Dahkki: Hopewell, J, et al.
Almmustuhtton: (2011)
C-reactive protein in the Heart Protection Study Reply
Dahkki: Emberson, J, et al.
Almmustuhtton: (2011)
N-terminal pro-B-type natriuretic peptide and vascular disease among 20,536 patients in the MRC/BHF heart protection study
Dahkki: Emberson, J, et al.
Almmustuhtton: (2005)